New research reveals how our breathing patterns can significantly influence memory formation, either enhancing or hindering ...
( NewsNation) — Dr. Ken Berry, a licensed family physician, brings up the medication’s risk to developing GLP-1 receptors. He ...
Thyroid cancer is a relatively rare type of cancer, but it is important to recognise the signs and symptoms of the disease, ...
A patient's delayed cancer diagnosis led to a medical malpractice lawsuit against her primary care doctor and endocrinologist ...
A 2017 study found that people experiencing migraine with nausea showed activity in the rostral dorsal medullary area of the brain, which likely controls nausea. Treatment for headaches and nausea ...
As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns ...
Italy: A recent analysis of the FDA Adverse Event Reporting System (FAERS) database has provided new insights into the safety ...
Data from the US FDA's Adverse Event Reporting System on tirzepatide showed adverse events generally consistent with those ...
Analysts have recently evaluated Exelixis and provided 12-month price targets. The average target is $29.4, accompanied by a high estimate of $33.00 and a low estimate of $27.00. This upward trend is ...
The list below includes contraindications of Wegovy. If you have a personal or family history of medullary thyroid carcinoma: To learn more, see the “Boxed warning” section. If you have ...
A phase 2 trial of ipilimumab plus nivolumab has met its primary end point of 12-month overall survival rate in non-clear ...
Compared with GLP-1 receptor agonists as a class, tirzepatide had generally a similar risk for gastrointestinal events and medullary thyroid cancer. It had better overall gastrointestinal tolerability ...